102 results
Search Results
2. Effects of sertraline on the pharmacokinetics of bupropion and its major metabolite, hydroxybupropion, in mice
3. The relationship between clinical pharmacokinetics of aripiprazole and CYP2D6 genetic polymorphism: effects of CYP enzyme inhibition by coadministration of paroxetine or fluvoxamine
4. Pharmacokinetics and antitumor activity of patupilone combined with midazolam or omeprazole in patients with advanced cancer
5. Evaluation of the pharmacokinetic interaction after multiple oral doses of linagliptin and digoxin in healthy volunteers
6. The CYP2C8 inhibitor gemfibrozil does not affect the pharmacokinetics of zafirlukast
7. Pharmacokinetic interaction between zolpidem and ciprofloxacin in healthy volunteers
8. Rifampicin reduces the plasma concentrations and the renin-inhibiting effect of aliskiren
9. Cannabis and benzodiazepines as determinants of methadone trough plasma concentration variability in maintenance treatment: a transnational study
10. Effect of nebicapone on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects
11. The effect of fluvoxamine on the pharmacokinetics, safety, and tolerability of ramosetron in healthy subjects
12. The effect of paroxetine on the pharmacokinetics, safety, and tolerability of ramosetron in healthy subjects
13. Effects of ursodeoxycholic acid on the pharmacokinetics and pharmacodynamics of intravenous and oral midazolam in healthy volunteers
14. Voriconazole and fluconazole increase the exposure to oral diazepam
15. Effect of efavirenz on the pharmacokinetics of ketoconazole in HIV-infected patients
16. Pharmacokinetics of desipramine HCl when administered with cinacalcet HCl
17. Lack of effect of ketoconazole-mediated CYP3A inhibition on sorafenib clinical pharmacokinetics
18. Effects of berberine on the blood concentration of cyclosporin A in renal transplanted recipients: clinical and pharmacokinetic study
19. Effect of aprepitant on the pharmacokinetics and pharmacodynamics of warfarin
20. Lack of effect of aprepitant on the pharmacokinetics of docetaxel in cancer patients
21. The effects of acute ethanol intake on isoniazid pharmacokinetics
22. Pharmacokinetic interaction between ketoconazole and imatinib mesylate (Glivec) in healthy subjects
23. Absence of significant pharmacokinetic and pharmacodynamic interactions between artemether and quinoline antimalarials
24. Clinical applications of fentanyl pharmacokinetics and pharmacodynamics: roles of fentanyl in anesthesia
25. Absence of interaction between erythromycin and a single dose of clozapine
26. Independent interaction of alprazolam and caffeine under chronic dose regimens on differential reinforcement of low-rate (DRL 45-s) performance
27. Combined effects of ethanol and cocaine on FOS-like protein and cocaethylene biosynthesis in the rat
28. Pharmacokinetic interaction between cyclosporine and the dihydropyridine calcium antagonist felodipine
29. Disposition of 5-formyl- and 5-methyltetrahydrofolic acid in serum after i.v. bolus of calcium folinate: pharmacokinetic drug interaction with preadministered interferon-alpha-2b
30. Influence of piroxicam coadministration on pharmacodynamic parameters and the plasma concentration/effect relationship of recombinant hirudin (CGP 39393)
31. Relative bioavailability of nicotine from a nasal spray in infectious rhinitis and after use of a topical decongestant
32. Azithromycin does not alter the effects of oral midazolam on human performance
33. A pharmacokinetic interaction between roxithromycin and midazolam
34. Kinetic interaction between theophylline and a newly developed anti-allergic drug, pemirolast potassium
35. Effect of metoclopramide and loperamide on the pharmacokinetics of didanosine in HIV seropositive asymptomatic male and female patients
36. The consequences of H2 receptor antagonist — piroxicam coadministration in patients with joint disorders
37. Effect of concomitant administration of cimetidine and ranitidine on the pharmacokinetics and electrocardiographic effects of terfenadine
38. Lack of a pharmacokinetic interaction between carvedilol and digitoxin or phenprocoumon
39. Lack of effect of magnesium-aluminium hydroxide on the absorption of theophylline given as a pH-dependent sustained release preparation
40. Metamizole-furosemide interaction study in healthy volunteers
41. Digoxin-interactions in man: Spironolactone reduces renal but not biliary digoxin clearance
42. Investigation of a possible pharmacokinetic interaction between ibopamine and isosorbide-5-mononitrate
43. Pharmacokinetics of cyclosporine in hyperlipidaemic long-term survivors of heart transplantation: Lack of interaction with the lipid-lowering agent, fenofibrate
44. Effect of salbutamol on digoxin pharmacokinetics
45. Pharmacokinetic pharmacodynamic evaluation of the combined administration of alprazolam and fluoxetine
46. Effect of omeprazole and cimetidine on plasma diazepam levels
47. Pharmacokinetic determination of relative potency of quinolone inhibition of caffeine disposition
48. The effects of frusemide and probenecid on the pharmacokinetics of phenprocoumon
49. Altered flecainide disposition in healthy volunteers taking quinine
50. Effect of mequitazine on the pharmacokinetics of theophylline in asthmatic patients
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.